The global safety needles market is expected to reach US$ 4.6 billion by 2028, growing at a CAGR of 9.9% during the forecast period. This growth is attributed to increasing awareness about the safety of healthcare workers and patients, growing prevalence of chronic diseases, and increasing demand for safety needles in developing countries.

Safety needles are medical devices that are designed to protect healthcare workers and patients from needle stick injuries. Needle stick injuries are accidental punctures of the skin with a contaminated needle, and they can transmit serious diseases such as HIV, hepatitis B, and hepatitis C. Safety needles are designed with a variety of features to prevent needle stick injuries, such as retractable needles, passive safety devices, and shielded needles.

Request A Sample Copy of This Research Report! https://bit.ly/49hV5Cz

Market Trends:

A number of trends are driving the growth of the safety needles market, including:

  • Increasing prevalence of blood-borne diseases: The prevalence of blood-borne diseases such as HIV, hepatitis B, and hepatitis C is increasing worldwide. This is driving the demand for safety needles to protect healthcare workers and patients from needle stick injuries.
  • Rising demand for injectable drugs and vaccines: The demand for injectable drugs and vaccines is increasing due to the growing prevalence of chronic diseases and the increasing number of vaccinations being administered. This is also driving the demand for safety needles.
  • Government initiatives to promote the use of safety needles: Governments around the world are implementing initiatives to promote the use of safety needles in healthcare settings. This is helping to raise awareness of the risks of needle stick injuries and the benefits of using safety needles.
  • Growing awareness of the risks of needle stick injuries: There is a growing awareness of the risks of needle stick injuries among healthcare workers and patients. This is driving the demand for safety needles.

Key Takeaways:

  • The global safety needles market is expected to reach US$ 4.6 billion by 2028, growing at a CAGR of 9.9% during the forecast period.
  • The increasing prevalence of chronic diseases, rising awareness of needlestick injuries, and government initiatives to promote the use of safety needles are driving the growth of the market.
  • Retractable safety syringes are the largest segment of the market, followed by non-retractable syringes.
  • Hospitals are the leading end-user segment, followed by clinics and ambulatory surgical centers.
  • North America is the largest regional market, followed by Europe and Asia Pacific.

Key Players:

  • BD
  • Terumo Medical Corporation
  • Becton, Dickinson and Company
  • Nipro Corporation
  • Cardinal Health
  • Medtronic
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Pfizer Inc.
  • AbbVie Inc.
  • Johnson & Johnson

Segmentation:

By Product:

  • Retractable safety syringes
  • Manual retractable safety syringes
  • Automatic retractable safety syringes
  • Non-retractable safety syringes

By End-use:

  • Hospitals
  • Clinics
  • Ambulatory surgical centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa